Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
3.330
+0.030 (0.91%)
Apr 30, 2026, 1:05 PM CST

SHE:002390 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2017
Cash & Equivalents
1,1141,016805.98899.18624.65
Upgrade
Cash & Short-Term Investments
1,1141,016805.98899.18624.65
Upgrade
Cash Growth
9.69%26.00%-10.37%43.95%-64.84%
Upgrade
Accounts Receivable
2,4682,6913,0363,0913,082
Upgrade
Other Receivables
256320.24324.63448.8600.56
Upgrade
Receivables
2,7243,0123,3613,5403,682
Upgrade
Inventory
901.231,0601,0011,033935.71
Upgrade
Prepaid Expenses
-0.020.030.020.02
Upgrade
Other Current Assets
103.97164.39243.61334.34333.72
Upgrade
Total Current Assets
4,8435,2525,4125,8065,576
Upgrade
Property, Plant & Equipment
2,3392,4262,5182,6722,706
Upgrade
Long-Term Investments
402.52337.47340.47343.84347.41
Upgrade
Goodwill
593.64603.75603.75607.35607.35
Upgrade
Other Intangible Assets
176.61189.54180.18204.37217.65
Upgrade
Long-Term Deferred Tax Assets
110.2781.8774.1462.8155.61
Upgrade
Long-Term Deferred Charges
58.1169.381.8497.21118.36
Upgrade
Other Long-Term Assets
6768.5735--
Upgrade
Total Assets
8,5919,0289,2459,7949,629
Upgrade
Accounts Payable
822.55927.97903.15977.24993.43
Upgrade
Accrued Expenses
22.3937.1535.2732.9940.93
Upgrade
Short-Term Debt
269.61603.54809.861,3681,390
Upgrade
Current Portion of Long-Term Debt
106.12----
Upgrade
Current Portion of Leases
-34.42.51-
Upgrade
Current Income Taxes Payable
30.167.621.0917.2117.79
Upgrade
Current Unearned Revenue
25.7725.9427.9833.2455.44
Upgrade
Other Current Liabilities
187.37201.68256.82255.56256.6
Upgrade
Total Current Liabilities
1,4641,8072,0592,6872,755
Upgrade
Long-Term Debt
37160---
Upgrade
Long-Term Leases
18.032121.1222.0224.81
Upgrade
Long-Term Unearned Revenue
20.2219.5222.0418.8920.38
Upgrade
Long-Term Deferred Tax Liabilities
13.190.730.840.56-
Upgrade
Other Long-Term Liabilities
0.280.290.310.320.34
Upgrade
Total Liabilities
1,5532,0082,1032,7292,800
Upgrade
Common Stock
1,9441,9441,9441,9442,027
Upgrade
Additional Paid-In Capital
4,4034,4034,4034,4024,693
Upgrade
Retained Earnings
569.93563.43633.34462.74354.99
Upgrade
Treasury Stock
-199.93-199.93-127.49--455.38
Upgrade
Comprehensive Income & Other
72.93----
Upgrade
Total Common Equity
6,7906,7106,8526,8086,620
Upgrade
Minority Interest
247.95309.87289.69256.55208.74
Upgrade
Shareholders' Equity
7,0387,0207,1427,0656,829
Upgrade
Total Liabilities & Equity
8,5919,0289,2459,7949,629
Upgrade
Total Debt
430.76787.55835.381,3931,415
Upgrade
Net Cash (Debt)
683.13227.97-29.4-493.42-790.6
Upgrade
Net Cash Growth
199.66%----
Upgrade
Net Cash Per Share
0.360.11-0.02-0.26-0.43
Upgrade
Filing Date Shares Outstanding
1,8981,8961,9071,9441,944
Upgrade
Total Common Shares Outstanding
1,8981,8961,9071,9441,944
Upgrade
Working Capital
3,3793,4453,3533,1192,822
Upgrade
Book Value Per Share
3.583.543.593.503.41
Upgrade
Tangible Book Value
6,0205,9176,0685,9975,795
Upgrade
Tangible Book Value Per Share
3.173.123.183.082.98
Upgrade
Buildings
-2,5172,5162,5782,396
Upgrade
Machinery
-1,7161,7221,6971,641
Upgrade
Construction In Progress
-145.0258.0624.9892.38
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.